Connection

Aryan Namboodiri to Humans

This is a "connection" page, showing publications Aryan Namboodiri has written about Humans.
Connection Strength

0.323
  1. Immunoglobulin GM and Fc?RIIIa genotypes influence cytotoxicity of neuroblastoma cells. J Neuroimmunol. 2014 May 15; 270(1-2):95-7.
    View in: PubMed
    Score: 0.018
  2. Humoral immunity to cytomegalovirus and chronic graft-versus-host disease. Viral Immunol. 2012 Aug; 25(4):338-40.
    View in: PubMed
    Score: 0.016
  3. The human cytomegalovirus TRL11/IRL11-encoded Fc?R binds differentially to allelic variants of immunoglobulin G1. Arch Virol. 2011 May; 156(5):907-10.
    View in: PubMed
    Score: 0.014
  4. Riluzole decreases synthesis of N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells. Brain Res. 2010 Jun 02; 1334:25-30.
    View in: PubMed
    Score: 0.014
  5. Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: implications for specialized acetyl coenzyme A metabolism in the CNS. Brain Res. 2010 Jun 04; 1335:1-13.
    View in: PubMed
    Score: 0.014
  6. Evidence for mitochondrial and cytoplasmic N-acetylaspartate synthesis in SH-SY5Y neuroblastoma cells. Neurochem Int. 2009 Sep; 55(4):219-25.
    View in: PubMed
    Score: 0.013
  7. Antipsychotic drugs increase N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells. J Neurochem. 2008 Aug; 106(4):1669-80.
    View in: PubMed
    Score: 0.012
  8. Hepatitis C virus core protein discriminates between the two IgG2 allotypes. Viral Immunol. 2008 Jun; 21(2):273-6.
    View in: PubMed
    Score: 0.012
  9. Fc gamma receptor-like hepatitis C virus core protein binds differentially to IgG of discordant Fc (GM) genotypes. Mol Immunol. 2007 Jul; 44(15):3805-8.
    View in: PubMed
    Score: 0.011
  10. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol. 2007 Feb; 81(2):89-131.
    View in: PubMed
    Score: 0.011
  11. Aspartoacylase is a regulated nuclear-cytoplasmic enzyme. FASEB J. 2006 Oct; 20(12):2139-41.
    View in: PubMed
    Score: 0.011
  12. Canavan disease and the role of N-acetylaspartate in myelin synthesis. Mol Cell Endocrinol. 2006 Jun 27; 252(1-2):216-23.
    View in: PubMed
    Score: 0.010
  13. Preface: a brief review of N-acetylaspartate. Adv Exp Med Biol. 2006; 576:vii-xiii.
    View in: PubMed
    Score: 0.010
  14. NAA synthesis and functional roles. Adv Exp Med Biol. 2006; 576:49-66; discussion 361-3.
    View in: PubMed
    Score: 0.010
  15. Defective myelin lipid synthesis as a pathogenic mechanism of Canavan disease. Adv Exp Med Biol. 2006; 576:145-63; discussion 361-3.
    View in: PubMed
    Score: 0.010
  16. Immunoglobulin ? chain allotypes and humoral immunity to HSV1 in Parkinson's disease. J Neuroimmunol. 2022 10 15; 371:577948.
    View in: PubMed
    Score: 0.008
  17. Immunoglobulin GM and KM allotypes are associated with antibody responses to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients. J Cyst Fibros. 2021 11; 20(6):1080-1084.
    View in: PubMed
    Score: 0.007
  18. Inhibitory Fc? Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease. J Alzheimers Dis. 2021; 84(3):965-968.
    View in: PubMed
    Score: 0.007
  19. The ketone ester, 3-hydroxybutyl-3-hydroxybutyrate, attenuates neurobehavioral deficits and improves neuropathology following controlled cortical impact in male rats. Nutr Neurosci. 2022 Jun; 25(6):1287-1299.
    View in: PubMed
    Score: 0.007
  20. Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial. Lancet HIV. 2019 10; 6(10):e667-e679.
    View in: PubMed
    Score: 0.007
  21. IGHG, IGKC, and FCGR genes and endogenous antibody responses to GARP in patients with breast cancer and matched controls. Hum Immunol. 2018 Aug; 79(8):632-637.
    View in: PubMed
    Score: 0.006
  22. Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. PLoS Med. 2018 01; 15(1):e1002493.
    View in: PubMed
    Score: 0.006
  23. Endogenous antibody responses to mucin 1 in a large multiethnic cohort of patients with breast cancer and healthy controls: Role of immunoglobulin and Fc? receptor genes. Immunobiology. 2018 02; 223(2):178-182.
    View in: PubMed
    Score: 0.006
  24. Immunoglobulin genotypes and cognitive functions in schizophrenia. Immunogenetics. 2018 01; 70(1):67-72.
    View in: PubMed
    Score: 0.006
  25. Genetic markers of immunoglobulin G and immunity to cytomegalovirus in patients with breast cancer. Cell Immunol. 2017 02; 312:67-70.
    View in: PubMed
    Score: 0.005
  26. The end of the road for the tryptophan depletion concept in pregnancy and infection. Clin Sci (Lond). 2016 08 01; 130(15):1327-33.
    View in: PubMed
    Score: 0.005
  27. Immunoglobulin G genotypes and the risk of schizophrenia. Hum Genet. 2016 10; 135(10):1175-9.
    View in: PubMed
    Score: 0.005
  28. Acetate as a Metabolic and Epigenetic Modifier of Cancer Therapy. J Cell Biochem. 2016 Mar; 117(3):574-88.
    View in: PubMed
    Score: 0.005
  29. Humoral Immunity to Cytomegalovirus Glycoprotein B in Patients With Breast Cancer and Matched Controls: Contribution of Immunoglobulin ?, ?, and Fc? Receptor Genes. J Infect Dis. 2016 Feb 15; 213(4):611-7.
    View in: PubMed
    Score: 0.005
  30. The decoy Fc? receptor encoded by the cytomegalovirus UL119-UL118 gene has differential affinity to IgG proteins expressing different GM allotypes. Hum Immunol. 2015 Aug; 76(8):591-4.
    View in: PubMed
    Score: 0.005
  31. Endogenous antibody responsiveness to epidermal growth factor receptor is associated with immunoglobulin allotypes and overall survival of patients with glioblastoma. Neuro Oncol. 2015 May; 17(5):678-84.
    View in: PubMed
    Score: 0.005
  32. Immunoglobulin genes influence the magnitude of humoral immunity to cytomegalovirus glycoprotein B. J Infect Dis. 2014 Dec 01; 210(11):1823-6.
    View in: PubMed
    Score: 0.005
  33. Acetate supplementation induces growth arrest of NG2/PDGFRa-positive oligodendroglioma-derived tumor-initiating cells. PLoS One. 2013; 8(11):e80714.
    View in: PubMed
    Score: 0.004
  34. Suggestive evidence that Fc variants of IgG2 and Fc?RIIa loci interact to contribute to the risk of prostate cancer. Hum Immunol. 2013 Dec; 74(12):1656-8.
    View in: PubMed
    Score: 0.004
  35. IGKC and Fc?R genotypes and humoral immunity to HER2 in breast cancer. Immunobiology. 2014 Feb; 219(2):113-7.
    View in: PubMed
    Score: 0.004
  36. N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells. J Biol Chem. 2013 Sep 06; 288(36):26188-26200.
    View in: PubMed
    Score: 0.004
  37. IgG and Fc?R genotypes and humoral immunity to mucin 1 in prostate cancer. Hum Immunol. 2013 Aug; 74(8):1030-3.
    View in: PubMed
    Score: 0.004
  38. Immunoglobulin genes and the acquisition of HIV infection in a randomized trial of recombinant adenovirus HIV vaccine. Virology. 2013 Jun 20; 441(1):70-4.
    View in: PubMed
    Score: 0.004
  39. A genetic variant of Fc?RIIIa is strongly associatedwith humoral immunity to cyclin B1 in African American patients with prostate cancer. Immunogenetics. 2013 Feb; 65(2):91-6.
    View in: PubMed
    Score: 0.004
  40. Genetic regulation of antibody responses to human epidermal growth factor receptor 2 in breast cancer. Hum Immunol. 2010 Nov; 71(11):1124-7.
    View in: PubMed
    Score: 0.003
  41. Genetic markers of IgG influence the outcome of infection with hepatitis C virus. J Infect Dis. 2008 Nov 01; 198(9):1334-6.
    View in: PubMed
    Score: 0.003
  42. IgG antibodies to human cytomegalovirus late protein UL94 in patients with systemic sclerosis. Autoimmunity. 2004 May; 37(3):241-4.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.